Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR”
Pharming Group announces that, effective today, its American Depositary Shares (“ADSs”) have been admitted for listing on the Nasdaq Global Market (“Nasdaq”) under the symbol “PHAR” and will begin trading tomorrow; Wednesday 23 December. Each ADS represents 10 of the Company’s ordinary shares of €0.01 nominal value (“Ordinary Shares”).
The United States Securities and Exchange Commission (“SEC”) has also declared “effective” the Company’s registration statements on Form F-1 and Form F-6, each filed with the SEC.
The Company has not registered any new issuance of securities in connection with this filing. The Company’s Ordinary Shares will continue to trade on Euronext Amsterdam.